Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Man

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Cell Death & Disease|March 4, 2011
Functional phosphoproteomic analysis reveals cold-shock domain protein A to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemiaD Sears, P Luong, M Yuan, et al.
Lasers in Surgery and Medicine|February 28, 2003
Raman spectroscopy for optical diagnosis in normal and cancerous tissue of the nasopharynx-preliminary findingsDavid P Lau, Zhiwei Huang, Harvey Lui, et al.
Bone Marrow Transplantation|May 30, 1998
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV diseaseD Gor, C Sabin, H G Prentice, et al.
International Journal of STD & AIDS|July 30, 2008
Would offering rapid point-of-care testing or non-invasive methods improve uptake of HIV testing among high-risk genitourinary medicine clinic attendees? A patient perspectiveS F Forsyth, E A Agogo, L Lau, et al.
The Journal of Clinical Investigation|April 20, 2000
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityG Klement, S Baruchel, J Rak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6M Evans, L K Borysiewicz, A S Evans, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 4, 2012
Uses and abuses of paediatric electroencephalographyW C Lee, S S Man, K W Lau, et al.
Cancer Research|February 10, 2000
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigensS J Youde, P R Dunbar, E M Evans, et al.
Cancer Metastasis Reviews|February 8, 2002
Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approachesR S Kerbel, J Yu, J Tran, et al.
Vaccine|March 21, 2001
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancerM Adams, L Borysiewicz, A Fiander, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Cell Death & Disease|March 4, 2011
Functional phosphoproteomic analysis reveals cold-shock domain protein A to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemiaD Sears, P Luong, M Yuan, et al.
Lasers in Surgery and Medicine|February 28, 2003
Raman spectroscopy for optical diagnosis in normal and cancerous tissue of the nasopharynx-preliminary findingsDavid P Lau, Zhiwei Huang, Harvey Lui, et al.
Bone Marrow Transplantation|May 30, 1998
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV diseaseD Gor, C Sabin, H G Prentice, et al.
International Journal of STD & AIDS|July 30, 2008
Would offering rapid point-of-care testing or non-invasive methods improve uptake of HIV testing among high-risk genitourinary medicine clinic attendees? A patient perspectiveS F Forsyth, E A Agogo, L Lau, et al.
The Journal of Clinical Investigation|April 20, 2000
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityG Klement, S Baruchel, J Rak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6M Evans, L K Borysiewicz, A S Evans, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 4, 2012
Uses and abuses of paediatric electroencephalographyW C Lee, S S Man, K W Lau, et al.
Cancer Research|February 10, 2000
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigensS J Youde, P R Dunbar, E M Evans, et al.
Cancer Metastasis Reviews|February 8, 2002
Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approachesR S Kerbel, J Yu, J Tran, et al.
Vaccine|March 21, 2001
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancerM Adams, L Borysiewicz, A Fiander, et al.
Pageof 15